217 related articles for article (PubMed ID: 14596765)
1. HIV-related lung cancer -- a growing concern?
Powles T; Nelson M; Bower M
Int J STD AIDS; 2003 Oct; 14(10):647-51. PubMed ID: 14596765
[TBL] [Abstract][Full Text] [Related]
2. HIV infection and cancer in the era of highly active antiretroviral therapy (Review).
Barbaro G; Barbarini G
Oncol Rep; 2007 May; 17(5):1121-6. PubMed ID: 17390054
[TBL] [Abstract][Full Text] [Related]
3. Smoke and mirrors: HIV-related lung cancer.
Bazoes A; Bower M; Powles T
Curr Opin Oncol; 2008 Sep; 20(5):529-33. PubMed ID: 19106655
[TBL] [Abstract][Full Text] [Related]
4. HIV-related malignancies pre- and post-highly active antiretroviral therapy: experiences in an inner city tertiary referral centre.
Kiely B; O'Flaherty J; Surah S; Kieran J; O'Donnell D; Bergin C; Mulcahy F
Int J STD AIDS; 2010 May; 21(5):332-6. PubMed ID: 20498102
[TBL] [Abstract][Full Text] [Related]
5. Does HIV adversely influence the outcome in advanced non-small-cell lung cancer in the era of HAART?
Powles T; Thirwell C; Newsom-Davis T; Nelson M; Shah P; Cox S; Gazzard B; Bower M
Br J Cancer; 2003 Aug; 89(3):457-9. PubMed ID: 12888811
[TBL] [Abstract][Full Text] [Related]
6. Malignancy-related causes of death in human immunodeficiency virus-infected patients in the era of highly active antiretroviral therapy.
Bonnet F; Lewden C; May T; Heripret L; Jougla E; Bevilacqua S; Costagliola D; Salmon D; Chêne G; Morlat P
Cancer; 2004 Jul; 101(2):317-24. PubMed ID: 15241829
[TBL] [Abstract][Full Text] [Related]
7. [Epidemiology of HIV-associated malignancies].
Launay O; Guillevin L
Bull Cancer; 2003 May; 90(5):387-92. PubMed ID: 12850760
[TBL] [Abstract][Full Text] [Related]
8. Cancer risk in the Swiss HIV Cohort Study: associations with immunodeficiency, smoking, and highly active antiretroviral therapy.
Clifford GM; Polesel J; Rickenbach M; Dal Maso L; Keiser O; Kofler A; Rapiti E; Levi F; Jundt G; Fisch T; Bordoni A; De Weck D; Franceschi S;
J Natl Cancer Inst; 2005 Mar; 97(6):425-32. PubMed ID: 15770006
[TBL] [Abstract][Full Text] [Related]
9. Delayed progression to death and to AIDS in a Hong Kong cohort of patients with advanced HIV type 1 disease during the era of highly active antiretroviral therapy.
Wong KH; Chan KC; Lee SS
Clin Infect Dis; 2004 Sep; 39(6):853-60. PubMed ID: 15472819
[TBL] [Abstract][Full Text] [Related]
10. The impact of highly active antiretroviral therapy on the incidence and outcomes of AIDS-defining cancers in Southern Alberta.
Gingues S; Gill MJ
HIV Med; 2006 Sep; 7(6):369-77. PubMed ID: 16903981
[TBL] [Abstract][Full Text] [Related]
11. Lung cancer, a new challenge in the HIV-infected population.
Lavolé A; Wislez M; Antoine M; Mayaud C; Milleron B; Cadranel J
Lung Cancer; 2006 Jan; 51(1):1-11. PubMed ID: 16300854
[TBL] [Abstract][Full Text] [Related]
12. Risk of cancers during interrupted antiretroviral therapy in the SMART study.
Silverberg MJ; Neuhaus J; Bower M; Gey D; Hatzakis A; Henry K; Hidalgo J; Lourtau L; Neaton JD; Tambussi G; Abrams DI
AIDS; 2007 Sep; 21(14):1957-63. PubMed ID: 17721103
[TBL] [Abstract][Full Text] [Related]
13. [HAART and changes of epidemiology, treatment and prognosis of HIV-positive patients with Kaposi's sarcoma and lymphoma].
Gabarre J; Bossi P
Bull Cancer; 2003 May; 90(5):419-25. PubMed ID: 12850765
[TBL] [Abstract][Full Text] [Related]
14. Incidence and prognosis of CMV disease in HIV-infected patients before and after introduction of combination antiretroviral therapy.
Salzberger B; Hartmann P; Hanses F; Uyanik B; Cornely OA; Wöhrmann A; Fätkenheuer G
Infection; 2005 Oct; 33(5-6):345-9. PubMed ID: 16258865
[TBL] [Abstract][Full Text] [Related]
15. Evolving epidemiology of malignancies in HIV.
Bonnet F; Chêne G
Curr Opin Oncol; 2008 Sep; 20(5):534-40. PubMed ID: 19106656
[TBL] [Abstract][Full Text] [Related]
16. [Diagnosis and treatment of HIV-related Kaposi's sarcoma].
Reyners AK; Sprenger HG; Suurmeijer AJ; van der Graaf WT
Ned Tijdschr Geneeskd; 2006 Mar; 150(11):589-93. PubMed ID: 16610494
[TBL] [Abstract][Full Text] [Related]
17. Cancer: the effects of HIV and antiretroviral therapy, and implications for early antiretroviral therapy initiation.
Grulich AE
Curr Opin HIV AIDS; 2009 May; 4(3):183-7. PubMed ID: 19532048
[TBL] [Abstract][Full Text] [Related]
18. AIDS-related malignancies: emerging challenges in the era of highly active antiretroviral therapy.
Cheung MC; Pantanowitz L; Dezube BJ
Oncologist; 2005; 10(6):412-26. PubMed ID: 15967835
[TBL] [Abstract][Full Text] [Related]
19. Malignancies in HIV: the Indian scenario.
Dhir AA; Sawant SP
Curr Opin Oncol; 2008 Sep; 20(5):517-21. PubMed ID: 19106653
[TBL] [Abstract][Full Text] [Related]
20. The growing problem of non-AIDS-defining malignancies in HIV.
Pantanowitz L; Schlecht HP; Dezube BJ
Curr Opin Oncol; 2006 Sep; 18(5):469-78. PubMed ID: 16894295
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
